Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study

Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study

Introduction To compare carotid intima–media thickness (cIMT) and liver fat content in subjects who maintained good glycemic control for 6 years on initial triple therapy with metformin/exenatide/pioglitazone versus sequential add-on therapy with metformin followed with glipizide and basal insulin i...

Full description

Saved in:
Bibliographic Details
Main Authors: JOHN ADAMS, Ralph A DeFronzo, Aurora Merovci, Curtis Triplitt, Muhammad Abdul-Ghani, Curtiss Puckett, Siham Abdelgani, Olga Lavrynenko
Format: Article
Language:English
Published: BMJ Publishing Group 2025-04-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/13/2/e004981.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items